Goodwin Procter LLP advised Hopin on the deal. Hopin, a leading virtual events provider, announced its $400 million Series C funding co-led by new investors Andreessen Horowitz...
Hopin’s $400 Million Series C funding
Evox Therapeutics’ £69.2 Million Series C Financing Round
Goodwin Procter LLP advised Evox Therapeutics on the deal. Evox Therapeutics, leading exosome therapeutics company, announced its £69.2 million Series C financing round. The financing was significantly...